Hydatidiform mole: clinical analysis of 310 patients

International Journal of Gynecology & Obstetrics - Tập 52 - Trang 233-236 - 1996
T. Mungan1, E. Kuşçu1, T. Dabakoǧlu1, S. Şenöz1, M. Uǧur1, Ö. Çobanoglu1
1Department of Gynecologic Oncology, Dr Zekai Tahir Burak Women's Hospital, Ankara, Turkey

Tóm tắt

AbstractObjectives: The aim of the study was to analyze the clinical characteristics, treatment and outcome of 310 patients with hydatidiform mole. Methods: Three hundred ten patients with hydatidiform mole admitted to Dr Zekai Tahir Burak Women's Hospital between 1989 and 1994, were evaluated retrospectively according to their clinical characteristics, treatment modalities and follow‐up. Results: The incidence of molar pregnancy was 2.48 per 1000 deliveries and 1.84 per 1000 pregnancies. The age of the patients ranged from 14 to 45 years with a mean age of 25.29 ± 7.40 years. In 60% of the patients, the molar pregnancy was their first pregnancy. A history of previous hydatidiform mole was found in 5.5% of the patients and eight of them had at least two previous molar pregnancies. The most common presenting symptom was vaginal bleeding (71%). Although theca‐lutein cysts were found in 17.1% of the patients, only one patient underwent emergency surgery because of torsion. Dilatation and suction curettage was the first‐line treatment; uterine perforation developed in two patients (0.6%). During follow‐up 14.5% of patients were diagnosed as persistent cases according to serum β‐human chorionic gonadotropin (β‐hCG) levels. Complete remission was achieved with the administration of 2–8 courses of single‐agent chemotherapy in 43 cases; combined chemotherapy (3–7 courses) was given to two patients who were resistant to single‐agent therapy. Conclusion: Comparison of patients with spontaneous remission and patients with persistent trophoblastic disease with respect to age, histologic type, previous history, initial uterine size, gravidity, presence of theca‐lutein cysts and initial β‐hCG levels did not reveal any of the above criteria to be prognostic for the occurrence of persistent disease.

Tài liệu tham khảo

Palmer JR, 1994, Advances in the epidemiology of gestational trophoblastic disease, J Reprod Med Obstet Gynecol, 3, 155 10.1016/S0140-6736(86)90179-0 10.1007/BF00144796 10.1093/oxfordjournals.humrep.a136622 10.1016/0002-9378(89)90248-2 10.1016/0020-7292(89)90608-5 Sand PK, 1984, Repeat gestational trophoblastic disease, Obstet Gynecol, 63, 140 Montz FJ, 1988, Natural history of theca lutein cysts, Obstet Gynecol, 2, 247 10.1097/00003081-198403000-00028 10.1016/0002-9378(91)90698-Q Goldstein DP, 1994, Gestational trophoblastic disease. A symposium, J Reprod Med Obstet Gynecol, 3, 137 Goldstein DP, 1994, Current management of complete and partial molar pregnancy, J Reprod Med Obstet Gynecol, 3, 139 10.1097/00006254-198708000-00002 Lurain JR, 1982, Gestational trophoblastic disease: treatment results at the Brewer Trophoblastic Disease Center, Obstet Gynecol, 60, 354 10.1016/S0002-9378(11)80033-5 10.1002/cncr.2820710430
Thông tin
Thông tin xuất bản

International Journal of Gynecology & Obstetrics

Tập 52

233-236

Thông tin tác giả